Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid. (Q44361901)
Jump to navigation
Jump to search
scientific article published in May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid. |
scientific article published in May 2009 |
Statements
Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid (English)
Michael Lein
Kurt Miller
Manfred Wirth
Lothar Weissbach
Christoph May
Katja Schmidt
Ulrike Haus
Mark Schrader